External validation of the Heidenreich criteria for patient selection for unilateral or bilateral retroperitoneal lymph node dissection for post-chemotherapy residual masses of testicular cancer. [electronic resource]
Producer: 20150814Description: 1573-8 p. digitalISSN:- 1433-8726
- Adult
- Antineoplastic Agents -- therapeutic use
- Cohort Studies
- Combined Modality Therapy
- Disease-Free Survival
- Humans
- Lymph Node Excision
- Male
- Neoplasm Recurrence, Local -- diagnosis
- Neoplasm, Residual
- Neoplasms, Germ Cell and Embryonal -- diagnosis
- Patient Selection
- Reproducibility of Results
- Retroperitoneal Space
- Testicular Neoplasms -- diagnosis
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.